Current Atherosclerosis Reports

, Volume 7, Issue 4, pp 263–267

Stroke as a complication of congenital heart disease

Authors

  • JiY Chong
    • Doris and Stanley Tananbaum Stroke Center, Neurological InstituteColumbia University Medical Center
  • Shunichi Homma
    • Doris and Stanley Tananbaum Stroke Center, Neurological InstituteColumbia University Medical Center
  • J. P. Mohr
    • Doris and Stanley Tananbaum Stroke Center, Neurological InstituteColumbia University Medical Center
Article

DOI: 10.1007/s11883-005-0017-1

Cite this article as:
Chong, J., Homma, S. & Mohr, J.P. Curr Atheroscler Rep (2005) 7: 263. doi:10.1007/s11883-005-0017-1

Abstract

Patent foramen ovale is a common finding in the general population. It is associated with an increased risk of stroke, but it may not have a significant effect on recurrent stroke risk in medically treated patients. Recently, many questions have arisen with respect to best treatment for preventing recurrent stroke. Some data from a clinical trial of anticoagulation compared with antiplatelet therapy support anti-platelet treatment for secondary prevention. There are not enough data currently to support surgical or percutaneous closure of patent foramen ovale for stroke prevention.

Download to read the full article text

Copyright information

© Current Science Inc 2005